• Granulomas in CD have been postulated to represent an adaptive mechanism for removal or localization of the causative agent because patients with a long clinical history show fewer granulomas than do those with a shorter clinical history. (medscape.com)
  • Chlamydia trachomatis are obligate intracellular bacterial pathogens that cause ocular and genital infections, which are a significant public health concern worldwide. (europa.eu)
  • A better understanding of C. trachomatis basic biology is important to eventually develop new ways to combat infections caused by these bacteria. (europa.eu)
  • Chlamydia trachomatis is a global cause of blinding trachoma and sexually transmitted infections (STIs). (cdc.gov)
  • Worldwide, C. trachomatis is the leading preventable cause of blindness and bacterial sexually transmitted infections (STIs). (cdc.gov)
  • Chlamydia is a major cause of sexually transmitted infections worldwide. (ufl.edu)
  • To screen for novel T3S effectors of C. trachomatis, we used Yersinia enterocolitica as a genetically tractable surrogate bacterial species assembling a T3S apparatus, which has been shown to recognise heterologous T3S substrates. (europa.eu)
  • Dr. Maurelli has over 30 years of research experience in the field of molecular genetics of bacterial pathogenesis, specifically in the study of Shigella and Chlamydia. (ufl.edu)
  • For this, specifically we aimed to (i) identify novel C. trachomatis type III secretion (T3S) effectors and (ii) further understand the secretion and function of known effectors. (europa.eu)
  • Lymphogranuloma venereum (LGV) is a sexually transmitted disease caused by Chlamydia trachomatis- specifically, serovars L1, L2, and L3. (medscape.com)
  • Chlamydia trachomatis is spread by close social contact or sexual activity. (cdc.gov)
  • To study the function of known effectors, we focused on the C. trachomatis Inc proteins, an important group of potential chlamydial virulence factors. (europa.eu)
  • Multilocus and SNP typing can now be used to detect diverse and emerging C. trachomatis strains for epidemiologic and evolutionary studies of trachoma and STI populations worldwide. (cdc.gov)
  • Chlamydia trachomatis is an obligate intracellular pathogen that replicates in a membrane-bound vacuole termed the inclusion. (nih.gov)
  • Enzootic abortion of ewes (EAE) due to infection with the obligate intracellular pathogen Chlamydia (C.) abortus is an important zoonosis leading to considerable economic loss to agriculture worldwide. (infektiologie.tirol)
  • Chlamydia trachomatis replicates primarily in the epithelial cells lining the genital tract and induces the innate immune response by triggering cellular pathogen recognition receptors (PRRs). (madridge.org)
  • Chlamydia trachomatis is a gram-negative, obligate intracellular bacterial pathogen causing the most common sexually transmitted infections (STI) worldwide, particularly among young women [1] . (madridge.org)
  • As per CDCʼs estimate, nearly 20 million healthy individuals are infected every year, accounting for almost $16 billion in health care costs annually (CDC 2016) [5] .The asymptomatic nature of C. trachomatis infection means that the pathogen persists for a long time in some individuals, which suggests the effective evasion of host immune systems [6 , 7] . (madridge.org)
  • Multilocus Sequence Typing of Urogenital Chlamydia trachomatis from Patients with Different Degrees of Clinical Symptoms. (immunogenetics.nl)
  • In women, chronic infection with the urogenital serovars (D-K) can cause pelvic inflammatory diseases (PID) and chronic pelvic pain, which can culminate into scarring and fibrosis of the Fallopian tubes leading to infertility or ectopic pregnancy [2 - 4] . (madridge.org)
  • Multilocus and SNP typing can now be used to detect diverse and emerging C. trachomatis strains for epidemiologic and evolutionary studies of trachoma and STI populations worldwide. (cdc.gov)
  • Certainly, the serovar-defining major outer membrane protein (MOMP) is a prime example of point mutation accumulation resulting in genetic variants, especially in the surface-exposed segments of this molecule. (medscape.com)
  • Evaluation of sexual history-based screening of anatomic sites for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men having sex with men in routine practice. (immunogenetics.nl)
  • however, the global effects of TLR3 signaling in the cellular response to Chlamydia infection in murine OE cells has not yet been investigated. (madridge.org)
  • To determine the impact of TLR3 signaling on Chlamydia infection in OE cell at the transcriptome level, we infected wild-type (OE-WT) and TLR3-deficient (OE-TLR3KO) cells with Cm , and performed transcriptome analyses using microarray. (madridge.org)
  • Lymphogranuloma venereum (LGV) is a sexually transmitted disease caused by Chlamydia trachomatis-specifically, serovars L1, L2, and L3. (medscape.com)
  • We used comparative genomics of the family Chlamydiaceae to select conserved housekeeping genes for C. trachomatis multilocus sequencing, characterizing 19 reference and 68 clinical isolates from 6 continental/subcontinental regions. (cdc.gov)
  • Genetic variation allows Chlamydia trachomatis to exploit diverse niches within a host (tissue tropism) and to avoid, escape or resist host responses. (medscape.com)
  • Genetic variation (lightning bolts) results in serovar-specific differences in invasiveness, evasion of host responses and tissue tropism. (medscape.com)
  • Analysis of the subcellular localization of both proteins throughout the developmental cycle revealed CAB063 being the first C. abortus protein shown to be translocated to the host cell nucleus. (infektiologie.tirol)
  • [ 35 ] There has also been strong bioinformatics evidence after whole-genome sequencing that chlamydiae have undergone a number of gene duplication events resulting in the creation of several families of proteins important for intracellular survival in cell culture and possibly in disease severity differences. (medscape.com)
  • There are a number of C. trachomatis gene products that exhibit variability and may modulate disease severity (Figure 3). (medscape.com)